BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18300229)

  • 1. NMR structure and dynamics of human ephrin-B2 ectodomain: the functionally critical C-D and G-H loops are highly dynamic in solution.
    Ran X; Qin H; Liu J; Fan JS; Shi J; Song J
    Proteins; 2008 Aug; 72(3):1019-29. PubMed ID: 18300229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the ephrin-B1 ectodomain: implications for receptor recognition and signaling.
    Nikolov DB; Li C; Barton WA; Himanen JP
    Biochemistry; 2005 Aug; 44(33):10947-53. PubMed ID: 16101278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and thermodynamic characterization of the EphB4/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity.
    Chrencik JE; Brooun A; Recht MI; Kraus ML; Koolpe M; Kolatkar AR; Bruce RH; Martiny-Baron G; Widmer H; Pasquale EB; Kuhn P
    Structure; 2006 Feb; 14(2):321-30. PubMed ID: 16472751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of an Eph receptor-ephrin complex.
    Himanen JP; Rajashankar KR; Lackmann M; Cowan CA; Henkemeyer M; Nikolov DB
    Nature; 2001 Dec 20-27; 414(6866):933-8. PubMed ID: 11780069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the ligand-binding domain of the receptor tyrosine kinase EphB2.
    Himanen JP; Henkemeyer M; Nikolov DB
    Nature; 1998 Dec; 396(6710):486-91. PubMed ID: 9853759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EphB2 and ephrin-B2 regulate the ionic homeostasis of vestibular endolymph.
    Dravis C; Wu T; Chumley MJ; Yokoyama N; Wei S; Wu DK; Marcus DC; Henkemeyer M
    Hear Res; 2007 Jan; 223(1-2):93-104. PubMed ID: 17158005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the human ephrin-A5 ectodomain.
    Nikolov D; Li C; Lackmann M; Jeffrey P; Himanen J
    Protein Sci; 2007 May; 16(5):996-1000. PubMed ID: 17400922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of EphB receptors and EphrinB ligands in the developing chick auditory brainstem.
    Cramer KS; Karam SD; Bothwell M; Cerretti DP; Pasquale EB; Rubel EW
    J Comp Neurol; 2002 Oct; 452(1):51-64. PubMed ID: 12205709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterization of the EphA4-Ephrin-B2 complex reveals new features enabling Eph-ephrin binding promiscuity.
    Qin H; Noberini R; Huan X; Shi J; Pasquale EB; Song J
    J Biol Chem; 2010 Jan; 285(1):644-54. PubMed ID: 19875447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of an ephrin ectodomain.
    Toth J; Cutforth T; Gelinas AD; Bethoney KA; Bard J; Harrison CJ
    Dev Cell; 2001 Jul; 1(1):83-92. PubMed ID: 11703926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling.
    Himanen JP; Chumley MJ; Lackmann M; Li C; Barton WA; Jeffrey PD; Vearing C; Geleick D; Feldheim DA; Boyd AW; Henkemeyer M; Nikolov DB
    Nat Neurosci; 2004 May; 7(5):501-9. PubMed ID: 15107857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of angiogenesis by Eph-ephrin interactions.
    Kuijper S; Turner CJ; Adams RH
    Trends Cardiovasc Med; 2007 Jul; 17(5):145-51. PubMed ID: 17574121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth.
    Chaudhari A; Mahfouz M; Fialho AM; Yamada T; Granja AT; Zhu Y; Hashimoto W; Schlarb-Ridley B; Cho W; Das Gupta TK; Chakrabarty AM
    Biochemistry; 2007 Feb; 46(7):1799-810. PubMed ID: 17249693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure and NMR binding reveal that two small molecule antagonists target the high affinity ephrin-binding channel of the EphA4 receptor.
    Qin H; Shi J; Noberini R; Pasquale EB; Song J
    J Biol Chem; 2008 Oct; 283(43):29473-84. PubMed ID: 18708347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the ligand-binding domain of the EphB2 receptor at 2 A resolution.
    Goldgur Y; Paavilainen S; Nikolov D; Himanen JP
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Feb; 65(Pt 2):71-4. PubMed ID: 19193989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR structure of biosynthetic engineered human insulin monomer B31(Lys)-B32(Arg) in water/acetonitrile solution. Comparison with the solution structure of native human insulin monomer.
    Bocian W; Borowicz P; Mikołajczyk J; Sitkowski J; Tarnowska A; Bednarek E; Głabski T; Tejchman-Małecka B; Bogiel M; Kozerski L
    Biopolymers; 2008 Oct; 89(10):820-30. PubMed ID: 18491415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using nuclear magnetic resonance spectroscopy to study molten globule states of proteins.
    Redfield C
    Methods; 2004 Sep; 34(1):121-32. PubMed ID: 15283921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ephrin-B2 immunoreactivity distribution in adult mouse brain.
    Migani P; Bartlett C; Dunlop S; Beazley L; Rodger J
    Brain Res; 2007 Nov; 1182():60-72. PubMed ID: 17945206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemometrical classification of ephrin ligands and Eph kinases using GRID/CPCA approach.
    Myshkin E; Wang B
    J Chem Inf Comput Sci; 2003; 43(3):1004-10. PubMed ID: 12767159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.
    Pfaff D; Héroult M; Riedel M; Reiss Y; Kirmse R; Ludwig T; Korff T; Hecker M; Augustin HG
    J Cell Sci; 2008 Nov; 121(Pt 22):3842-50. PubMed ID: 18957513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.